"Oncology flows degrade silently — and nobody sees it until the damage is done."
- Delays in diagnostics, biopsies and multidisciplinary committees accumulate invisibly
- Patient follow-up is lost without a structural early warning mechanism
- Structural backlogs and saturation remain undetected until they reach a critical threshold
- Unnecessary treatment escalations generate avoidable cost and worse patient outcomes
CareMargin introduces two parallel operational margins as an intelligent signal layer within the systems already in use (NOUSIS · PADWIN · PACS). It does not replace clinical decision-making — it improves operational visibility, prioritisation and workflow stability.
Oncology Operational Stability Margin
Monitors patient flow stability across diagnostics, pathology, committee scheduling and treatment pathways.
Economic Operational Margin – Hospital
Tracks the economic sustainability of oncology flow: cost escalation risk, resource pressure and avoidable spend.
Access the Clinical Oversight platform
No credentials yet? Request a pilot discussion — we will reach out to explore whether CareMargin is the right fit for your oncology service.